In its second major partnership with a big pharma group, UK-based AI and multi-omics company Relation Therapeutics has agreed to seek out targets for allergic diseases on behalf of Novartis. The ...
Novartis has tapped up an artificial-intelligence-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for immuno-dermatology conditions. What caught the Swiss pharma’s eye ...
Bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) is a ubiquitous bacterial second-messenger molecule that is involved in the molecular decision between planktonic motile and sedentary ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Since the launch of the Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced the Mini Crossword — followed by Spelling Bee, Letter ...
We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Learn what a crypto wallet is and how to create one Manoj is a writer who ...
Every year, CFR’s Preventive Priorities Survey analyzes existing and potential conflicts throughout the world in terms of likelihood and possible impact. As the second Trump administration reorders ...
Breaking:The U.S. has attacked Venezuela and captured its leader, Nicolás Maduro. Read our full coverage. The writer extols the virtues of immersing oneself in nature and laments the inevitable ...
The future of defense strategy requires restructuring forces for modern threats, focusing deployments on critical regions, accelerating tech integration, reforming procurement and budgets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback